Clinical Trial Update: Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG) [NA]

View source ↗

Summary

A clinical trial is evaluating the efficacy and safety of HN2302 for refractory myasthenia gravis. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• HN2302

Snippet

Sponsor: The Affiliated Hospital of Xuzhou Medical University | Conditions: Refractory Myasthenia Gravis | NA | Status: RECRUITING